Prevention of Zika Virus

Zika virus is transmitted by the Aedes aegypti and Aedes albopictus mosquitoes through bites. It can also be transmitted from mother to her child during pregnancy, through sexual contact, through blood transfusion, and through laboratory exposure. Learn more in ACOG's Committee Opinion on Zika Virus.

CDC continues to encourage women considering pregnancy and their partners in areas with Zika to talk to their healthcare providers about pregnancy planning to learn the risks and the ways to reduce them. For more information:

Avoiding Bites from Infected Mosquitoes

Sexual Transmission

Zika can be transmitted sexually by an infected partner, even if they are asymptomatic. Learn more in ACOG’s Practice Advisory on Zika.  

View ACOG's Reproductive Counseling and Zika Virus webpage for additional resources for providers. 

Donated blood and blood components in the US

FDA advises testing for Zika virus in all donated blood and blood components in the US. As a further safety measure against the emerging Zika virus outbreak, the FDA issued revised guidance recommending universal testing of donated Whole Blood and blood components for Zika virus in the United States and its territories. The updated guidance recommends that all states and US territories screen individual units of donated Whole Blood and blood components with a blood screening test authorized for use by the FDA under an investigational new drug (IND) application, or a licensed test when available. Alternatively, an FDA-approved pathogen-reduction device may be used for plasma and certain platelet products.


American College of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188
Mailing Address: PO Box 96920, Washington, DC 20024-9998